2023
DOI: 10.1124/dmd.123.001345
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Xenobiotic and Steroid Disposition Potential of Human Placental Tissue and Cell Lines (BeWo, JEG-3, JAR, and HTR-8/SVneo) by Quantitative Proteomics

Abstract: Non-standard Abbreviations: -Iodoacetamide (IAA) -Bovine Serum Albumin (BSA) -Dithiothreitol (DTT) -Label free quantification (LFQ) -Di(2-ethylhexyl) (DEHP) -Diisononyl (DINP)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…Examples of this work include: an evaluation of BeWo, JAR, JEG-3, and HTR-8/SVneo cells as a suitable model for preeclampsia drug screening [13], an assessment of BeWo, JAR, JEG-3, and ACH-3P as models for endocrine and transport studies [10], and DNA methylation profiling of JAR, BeWo, JEG-3, HTR-8/SVneo, AC1M-32, TEV-1, and SWAN71 [14]. Additional studies include an analysis of HTR-8/SVneo, JEG-3, JAR and BeWo for epithelial and mesenchymal cell markers [7], studies of invasive properties of HTR-8/SVneo and JEG-3 cells [15,16], a quantitative proteomic evaluation of xenobiotic and steroid metabolizing enzymes in placental tissue and BeWo, JEG-3, JAR, and HTR-8/SVneo cell lines [17], as well as studies of single genes or small gene subsets across multiple placental cell lines [18,19]. Overall, these studies reveal that in vitro models of the human placenta have individual strengths that should be considered during model selection; however, they have not directly compared these models to human placental tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Examples of this work include: an evaluation of BeWo, JAR, JEG-3, and HTR-8/SVneo cells as a suitable model for preeclampsia drug screening [13], an assessment of BeWo, JAR, JEG-3, and ACH-3P as models for endocrine and transport studies [10], and DNA methylation profiling of JAR, BeWo, JEG-3, HTR-8/SVneo, AC1M-32, TEV-1, and SWAN71 [14]. Additional studies include an analysis of HTR-8/SVneo, JEG-3, JAR and BeWo for epithelial and mesenchymal cell markers [7], studies of invasive properties of HTR-8/SVneo and JEG-3 cells [15,16], a quantitative proteomic evaluation of xenobiotic and steroid metabolizing enzymes in placental tissue and BeWo, JEG-3, JAR, and HTR-8/SVneo cell lines [17], as well as studies of single genes or small gene subsets across multiple placental cell lines [18,19]. Overall, these studies reveal that in vitro models of the human placenta have individual strengths that should be considered during model selection; however, they have not directly compared these models to human placental tissue.…”
Section: Introductionmentioning
confidence: 99%